quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:29:19·24d
SECFiling
NeuroSense Therapeutics Ltd. logo

SEC Form 20-F filed by NeuroSense Therapeutics Ltd.

NRSN· NeuroSense Therapeutics Ltd.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • NRSN
    NeuroSense Therapeutics Ltd.
    Health Care

Recent analyst ratings

  • Jan 7UpdateMaxim Group$7.00

Related

  • SEC4h
    SEC Form 6-K filed by NeuroSense Therapeutics Ltd.
  • SEC18d
    SEC Form 6-K filed by NeuroSense Therapeutics Ltd.
  • PR18d
    NeuroSense Granted Brazilian Patent Covering PrimeC Composition
  • PR21d
    NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
  • SEC21d
    SEC Form 6-K filed by NeuroSense Therapeutics Ltd.
  • INSIDER22d
    SEC Form 4 filed by Eisenberg Or
  • INSIDER22d
    SEC Form 3 filed by new insider Eisenberg Or
  • INSIDER23d
    SEC Form 3 filed by new insider Mandil-Levin Revital
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022